Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2534 | 2215 | 36.4 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
416 | 3 | NEUROENDOCRINE TUMORS//CARCINOID//SMALL CELL CARCINOMA | 28897 |
808 | 2 | RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//ANTIBODY DRUG CONJUGATE | 12023 |
2534 | 1 | PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//RADIOL CHEM//PRRT | 2215 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEPTIDE RECEPTOR RADIONUCLIDE THERAPY | authKW | 725734 | 3% | 71% | 74 |
2 | RADIOL CHEM | address | 693703 | 3% | 70% | 72 |
3 | PRRT | authKW | 651259 | 3% | 75% | 63 |
4 | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | authKW | 635063 | 4% | 48% | 96 |
5 | SOMATOSTATIN RECEPTOR | authKW | 535851 | 8% | 22% | 180 |
6 | CELL BIOL EXPT CANC | address | 449721 | 3% | 43% | 76 |
7 | LU 177 DOTATATE | authKW | 425322 | 2% | 86% | 36 |
8 | NEUROENDOCRINE TUMOURS | authKW | 362788 | 5% | 23% | 116 |
9 | NEUROENDOCRINE TUMORS | authKW | 362476 | 10% | 12% | 223 |
10 | NUCL MED | address | 319145 | 44% | 2% | 981 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 44950 | 55% | 0% | 1213 |
2 | Oncology | 1533 | 15% | 0% | 340 |
3 | Nuclear Science & Technology | 732 | 6% | 0% | 134 |
4 | Endocrinology & Metabolism | 402 | 6% | 0% | 142 |
5 | Chemistry, Inorganic & Nuclear | 379 | 6% | 0% | 126 |
6 | Medicine, Research & Experimental | 347 | 6% | 0% | 129 |
7 | Chemistry, Medicinal | 298 | 4% | 0% | 93 |
8 | Biochemical Research Methods | 203 | 4% | 0% | 92 |
9 | Pharmacology & Pharmacy | 123 | 7% | 0% | 157 |
10 | Gastroenterology & Hepatology | 73 | 3% | 0% | 57 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RADIOL CHEM | 693703 | 3% | 70% | 72 |
2 | CELL BIOL EXPT CANC | 449721 | 3% | 43% | 76 |
3 | NUCL MED | 319145 | 44% | 2% | 981 |
4 | MOL RADIOPHARM | 165407 | 1% | 100% | 12 |
5 | MAT RADIACT | 142185 | 1% | 74% | 14 |
6 | RADIOL CHEM UNIT | 137839 | 0% | 100% | 10 |
7 | INRASTES | 103002 | 1% | 36% | 21 |
8 | ENETS EXCELLENCE | 57499 | 0% | 38% | 11 |
9 | DIAGNOST IMAGING RADIOISOTOPE THER Y SERV | 57431 | 0% | 83% | 5 |
10 | RADIOPHARMACEUT SCI | 56036 | 2% | 12% | 35 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 142740 | 8% | 6% | 182 |
2 | JOURNAL OF NUCLEAR MEDICINE | 105038 | 13% | 3% | 278 |
3 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 51665 | 3% | 5% | 74 |
4 | EJNMMI RESEARCH | 47795 | 2% | 9% | 39 |
5 | NUCLEAR MEDICINE AND BIOLOGY | 41227 | 5% | 3% | 105 |
6 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 33014 | 2% | 7% | 36 |
7 | NUCLEAR MEDICINE COMMUNICATIONS | 18599 | 3% | 2% | 75 |
8 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 14255 | 3% | 2% | 58 |
9 | MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 14121 | 1% | 4% | 27 |
10 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | 11508 | 1% | 6% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEPTIDE RECEPTOR RADIONUCLIDE THERAPY | 725734 | 3% | 71% | 74 | Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY | Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY |
2 | PRRT | 651259 | 3% | 75% | 63 | Search PRRT | Search PRRT |
3 | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | 635063 | 4% | 48% | 96 | Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY | Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY |
4 | SOMATOSTATIN RECEPTOR | 535851 | 8% | 22% | 180 | Search SOMATOSTATIN+RECEPTOR | Search SOMATOSTATIN+RECEPTOR |
5 | LU 177 DOTATATE | 425322 | 2% | 86% | 36 | Search LU+177+DOTATATE | Search LU+177+DOTATATE |
6 | NEUROENDOCRINE TUMOURS | 362788 | 5% | 23% | 116 | Search NEUROENDOCRINE+TUMOURS | Search NEUROENDOCRINE+TUMOURS |
7 | NEUROENDOCRINE TUMORS | 362476 | 10% | 12% | 223 | Search NEUROENDOCRINE+TUMORS | Search NEUROENDOCRINE+TUMORS |
8 | GA 68 | 316422 | 3% | 35% | 65 | Search GA+68 | Search GA+68 |
9 | IN 111 PENTETREOTIDE | 299470 | 2% | 56% | 39 | Search IN+111+PENTETREOTIDE | Search IN+111+PENTETREOTIDE |
10 | GA 68 DOTANOC | 297223 | 1% | 74% | 29 | Search GA+68+DOTANOC | Search GA+68+DOTANOC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | EBERLE, AN , MILD, G , FROIDEVAUX, S , (2004) RECEPTOR-MEDIATED TUMOR TARGETING WITH RADIOPEPTIDES. PART 1. GENERAL CONCEPTS AND METHODS: APPLICATIONS TO SOMATOSTATIN RECEPTOR-EXPRESSING TUMORS.JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION. VOL. 24. ISSUE 4. P. 319-455 | 298 | 55% | 10 |
2 | LAVERMAN, P , SOSABOWSKI, JK , BOERMAN, OC , OYEN, WJG , (2012) RADIOLABELLED PEPTIDES FOR ONCOLOGICAL DIAGNOSIS.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 39. ISSUE . P. 78-92 | 95 | 81% | 26 |
3 | FANI, M , MAECKE, HR , OKARVI, SM , (2012) RADIOLABELED PEPTIDES: VALUABLE TOOLS FOR THE DETECTION AND TREATMENT OF CANCER.THERANOSTICS. VOL. 2. ISSUE 5. P. 481-501 | 92 | 68% | 85 |
4 | SCHOTTELIUS, M , WESTER, HJ , (2009) MOLECULAR IMAGING TARGETING PEPTIDE RECEPTORS.METHODS. VOL. 48. ISSUE 2. P. 161 -177 | 119 | 58% | 111 |
5 | AMBROSINI, V , FANI, M , FANTI, S , FORRER, F , MAECKE, HR , (2011) RADIOPEPTIDE IMAGING AND THERAPY IN EUROPE.JOURNAL OF NUCLEAR MEDICINE. VOL. 52. ISSUE . P. 42S -55S | 85 | 79% | 56 |
6 | FANI, M , MAECKE, HR , (2012) RADIOPHARMACEUTICAL DEVELOPMENT OF RADIOLABELLED PEPTIDES.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 39. ISSUE . P. 11-30 | 87 | 69% | 70 |
7 | LO RUSSO, G , PUSCEDDU, S , PRINZI, N , IMBIMBO, M , PROTO, C , SIGNORELLI, D , VITALI, M , GANZINELLI, M , MACCAURO, M , BUZZONI, R , ET AL (2016) PEPTIDE RECEPTOR RADIONUCLIDE THERAPY: FOCUS ON BRONCHIAL NEUROENDOCRINE TUMORS.TUMOR BIOLOGY. VOL. 37. ISSUE 10. P. 12991 -13003 | 81 | 84% | 0 |
8 | TEUNISSEN, JJM , KWEKKEBOOM, DJ , VALKEMA, R , KRENNING, EP , (2011) NUCLEAR MEDICINE TECHNIQUES FOR THE IMAGING AND TREATMENT OF NEUROENDOCRINE TUMOURS.ENDOCRINE-RELATED CANCER. VOL. 18. ISSUE . P. S27-S51 | 92 | 70% | 36 |
9 | DONG, C , LIU, Z , WANG, F , (2014) PEPTIDE-BASED RADIOPHARMACEUTICALS FOR TARGETED TUMOR THERAPY.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 1. P. 139 -152 | 85 | 72% | 5 |
10 | POOL, SE , KRENNING, EP , KONING, GA , VAN EIJCK, CHJ , TEUNISSEN, JJM , KAM, B , VALKEMA, R , KWEKKEBOOM, DJ , DE JONG, M , (2010) PRECLINICAL AND CLINICAL STUDIES OF PEPTIDE RECEPTOR RADIONUCLIDE THERAPY.SEMINARS IN NUCLEAR MEDICINE. VOL. 40. ISSUE 3. P. 209-218 | 75 | 78% | 47 |
Classes with closest relation at Level 1 |